Hepatocyte Growth Factor Contributes to Fracture Repair by Upregulating the Expression of BMP Receptors
- 1 October 2005
- journal article
- Published by Oxford University Press (OUP) in Journal of Bone and Mineral Research
- Vol. 20 (10) , 1723-1730
- https://doi.org/10.1359/jbmr.050607
Abstract
Hepatocyte growth factor (HGF) is activated and the expression of BMP receptors (BMPRs) is induced around the fracture site during the early phase of fracture repair. HGF facilitates the expression of BMPRs in mesenchymal cells. This study suggests that HGF contributes to fracture repair by inducing the expression of BMPRs. The precise mechanisms that control the upregulation of BMP, BMPRs, and other molecules involved in bone repair are not completely understood. In this study, we hypothesized that HGF, activated through the action of thrombin on the HGF activator, may enhance BMP action through the local induction of BMP or BMPRs. Callus samples from tibial fractures in mice were harvested for immunohistochemical analysis of HGF and phosphorylated c-Met, for in situ hybridization of BMPRs, and for real-time RT-PCR analysis for the expression of HGF, c-Met, and BMPRs. To study the changes in gene expression of BMPRs in response to HGF, C3H10T1/2 cells were cultured with or without HGF and harvested for real-time RT-PCR and for Western blot analysis. To evaluate the contribution of HGF to the biological action of BMP2, C3H10T1/2 cells and primary muscle-derived mesenchymal cells were precultured with HGF and cultured with BMP2. In addition, the expression of the luciferase gene linked to the Id1 promoter containing the BMP responsive element and alkaline phosphatase (ALP) activity were assayed. Positive immunostaining of HGF and phosphorylated c-Met was detected around the fracture site at 1 day after the fracture was made. mRNA expression of BMPRs was increased 1 day after fracture and localized in mesenchymal cells at the fracture site. From an in vitro study, the expression of mRNA for BMPRs was elevated by treatment with HGF, but the expression of BMP4 did not change. Western blot analysis also showed the upregulation of BMPR2 by HGF treatment. The results from the luciferase and ALP assays indicated increased responsiveness to BMPs by treating with HGF. This study indicates that HGF is activated and expressed at the fracture site and that HGF induces the upregulation of BMPRs in mesenchymal cells. Furthermore, HGF may facilitate BMP signaling without altering the expression of BMP molecules.Keywords
This publication has 28 references indexed in Scilit:
- Towards an Effective Gene Therapy for Idiopathic Pulmonary FibrosisChest, 2002
- Hepatocyte growth factor: Renotropic role and potential therapeutics for renal diseasesKidney International, 2001
- Colocalization of Noggin and Bone Morphogenetic Protein-4 During Fracture HealingJournal of Bone and Mineral Research, 2001
- Myocardial protection from ischemia/reperfusion injury by endogenous and exogenous HGFJournal of Clinical Investigation, 2000
- Signal transduction by bone morphogenetic protein receptors: functional roles of Smad proteinsBone, 1999
- Hepatocyte growth factor gene therapy of liver cirrhosis in ratsNature Medicine, 1999
- Enhanced expression of type I receptors for bone morphogenetic proteins during bone formationJournal of Bone and Mineral Research, 1995
- Significant amount of hepatocyte growth factor detected in blood and bone marrow plasma of leukaemia patientsBritish Journal of Haematology, 1994
- Transient and localized expression of bone morphogenetic protein 4 messenger RNA during fracture healingJournal of Bone and Mineral Research, 1994
- Novel Regulators of Bone Formation: Molecular Clones and ActivitiesScience, 1988